J&J's first-quarter profit beats estimates even as Stelara sales disappoint - Reuters
Reuters
—
Johnson & Johnson earnings beat
- J&Jās first-quarter profit beats estimates even as Stelara sales disappoint CTV News —
- J&Jās first-quarter profit beats estimates even as Stelara sales disappoint The Globe and Mail —
- J&Jās First-Quarter Sales Grow on Cancer-Drug Strength Wall Street Journal —
- Johnson & Johnson Non-GAAP EPS of $2.70 beats by $0.02, revenue of $24.06B beats by $450M Seeking Alpha —
- Earnings Snapshot: Johnson & Johnson tops Q1 expectations; boosts full-year outlook and increases quarterly dividend Seeking Alpha —